FDA Drug Application (091620) for TIGECYCLINE by SANDOZ INC

Back to FDA Applications sponsored by SANDOZ INC

Application Number091620
Product Number001
FormINJECTABLE;IV (INFUSION)
Dosage50MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameTIGECYCLINE
Active IngredientTIGECYCLINE

Active IngredientCount
List of drugs with Active Ingredient TIGECYCLINE2


Back to FDA Applications sponsored by SANDOZ INC